A Day Up For Assertio Therapeutics, Inc.
Thu, Dec 16, 2021 at 05:30 PM
Assertio Therapeutics, Inc. (ASRT:NASDAQ) rocketted at $1.67, representing a gain of 23.7%. On Wed, Dec 15, 2021, ASRT:NASDAQ touched a New 2-Week Intraday Low of $1.26. The stock appeared on our News Catalysts scanner on Wed, Dec 15, 2021 at 06:23 PM in the 'ACQUISITION' category. From Wed, Dec 01, 2021, the stock recorded 40.00% Up Days and 45.45% Green Days
The stock spiked on Fri, Nov 12, 2021 at $1.65 with a volume of 2M+.
About Assertio Therapeutics, Inc. (ASRT:NASDAQ)
Depomed Inc is a specialty pharmaceutical company focused on pain and other conditions and diseases of the central nervous system.
Top 10 Gainers:
- ADGI (ADGI:NASDAQ), 123.31%
- XFIN (XFIN:NASDAQ), 100%
- Kaixin Auto Holdings (KXIN:NASDAQ), 36.29%
- Assertio Therapeutics, Inc. (ASRT:NASDAQ), 23.7%
- Aptose Biosciences Inc. (APTO:NASDAQ), 23.53%
- CALT (CALT:NASDAQ), 22.29%
- Arcturus Therapeutics Holdings Inc. (ARCT:NASDAQ), 21.06%
- Zai Lab Limited (ZLAB:NASDAQ), 20.69%
- BSN (BSN:NYSE), 19.06%
- X4 Pharmaceuticals, Inc. (XFOR:NASDAQ), 17.33%